Beijing Lu Daopei Hematology Hospital

This study integrates multiple diseases, breaking down their causes, symptoms, and key diagnostic and treatment points.

Hospital Overview

Beijing Lu Daopei Hematology Hospital is a tertiary hematology specialty hospital affiliated with Lu Daopei Medical Group. Established in 2020 and located in Shunyi District, Beijing, the hospital covers nearly 50,000 square meters and focuses on the diagnosis and treatment of hematological diseases, with particular strengths in hematopoietic stem cell transplantation, hematological malignancies, immunotherapy, and precision diagnostics.

City

Located in Gaoliying Town, Shunyi District, Beijing, China.

Hospital Positioning

A tertiary hematology specialty hospital dedicated to the diagnosis and treatment of hematological diseases.

Regional Medical

Part of Lu Daopei Medical Group’s four-hospital medical system, with specialized expertise in hematopoietic stem cell transplantation and comprehensive hematology care.

2020

Established

~50,000 m²

Hospital Area

Class 100 Laminar Flow Rooms

1,275

HSCT Cases

10+

Specialized Departments

Core treatment areas

Routine Diagnosis and Treatment

Comprehensive diagnosis and treatment of hematological diseases, including leukemia, lymphoma, multiple myeloma, aplastic anemia, bleeding disorders, and other malignant and non-malignant blood diseases. Treatment options include chemotherapy, immunotherapy, targeted therapy, CAR-T cell therapy, and hematopoietic stem cell transplantation.

Core Advantages

In April 2021, the hospital joined forces with Peking University People’s Hospital Hematology Research Institute, with Academician Huang Xiaojun, Director of the Institute, leading the establishment of a Hematology Joint Ward. The Lu Daopei medical team completes allogeneic hematopoietic stem cell transplants accounting for 10% of the national total. In December 2024, the hospital was designated as the “Blood Disease Specialist Doctor/Nurse Training Base of China Non-public Medical Institutions Association”.

Authoritative Qualifications and International Medical Collaboration

Specialized hematology qualifications, leading institutional collaboration, and stem cell donor partnerships support comprehensive hematological care.

International Certifications

China Marrow Donor Program Cooperation

Cooperation for unrelated hematopoietic stem cell donor search and matching.

Taiwan Tzu Chi Marrow Stem Cell Center Cooperation

Cross-regional collaboration supporting hematopoietic stem cell donor resources.

Cord Blood Bank Cooperation

Cooperation with designated cord blood banks affiliated with the China Marrow Donor Program.

Global Partnerships

Peking University People's Hospital Collaboration

A Hematology Joint Ward was established with the Hematology Research Institute of Peking University People's Hospital in April 2021.

Academician-Led Hematology Collaboration

The joint ward is led by Academician Huang Xiaojun, Director of the Hematology Research Institute of Peking University People's Hospital.

China Marrow Donor Program

Collaboration supports unrelated hematopoietic stem cell donor search and matching for transplantation patients.

Specialized Qualifications

Designated Medical Institution under Beijing Medical Insurance.

Blood Disease Specialist Doctor/Nurse Training Base of China Non-public Medical Institutions Association (2024).

National Drug Clinical Trial Institution Qualification in Hematology and Drug Clinical Trial Institution Filing.

Drafted and published the group standard "Requirements for Clinical Test Reports of Flow Cytometry" (T/CITS 670—2025).

Specialty Centers & Core Medical Sciences

Specialized transplantation, hematology, lymphoma and myeloma care, and precision laboratory diagnostics supported by experienced clinical teams.

HSCT

Hematopoietic Stem Cell Transplantation

HEM

General Hematology

LMC

Lymphoma & Myeloma Center

PLM

Pathology & Laboratory Medicine

Leading key specialties

Hematopoietic Stem Cell Transplantation

Department Overview

The Hematopoietic Stem Cell Transplantation Department is the hospital’s core department and one of the most active transplantation centers internationally. The department has an experienced team of transplantation experts with extensive experience in various hematopoietic stem cell transplantation techniques including haploidentical transplantation, unrelated transplantation, sibling matched transplantation, and cord blood transplantation. The department director is Professor Liu Kaiyan.

Core Technologies

Haploidentical Hematopoietic Stem Cell Transplantation – Between parents and children
Unrelated Donor Hematopoietic Stem Cell Transplantation
Sibling Matched Hematopoietic Stem Cell Transplantation
Cord Blood Hematopoietic Stem Cell Transplantation
CAR-T Cell Therapy – Chimeric Antigen Receptor T-cell immunotherapy
Transplantation Complication Management – GVHD, TMA, infections, etc.

Areas of expertise:

Hematopoietic stem cell transplantation.
Management of transplantation complications.
Complex hematological diseases requiring transplantation.

Leading key specialties

General Hematology

Department Overview

The General Hematology Department mainly provides chemotherapy, differentiation therapy, immunotherapy (including monoclonal antibodies, bispecific antibodies, etc.), targeted therapy, small molecule drugs, autologous hematopoietic stem cell transplantation, and traditional Chinese medicine for hematological malignancies. It also has unique diagnostic and treatment experience for non-malignant hematological diseases.

Core Technologies

Chemotherapy – Acute leukemia, lymphoma, myeloma
Immunotherapy – Monoclonal antibodies, bispecific antibodies
Targeted Therapy – Molecular targeted drugs
Autologous Hematopoietic Stem Cell Transplantation – Lymphoma, myeloma
CAR-T Cell Therapy – Relapsed and refractory cases

Areas of expertise:

Malignant hematological diseases.
Leukemia, lymphoma, and multiple myeloma.
Chemotherapy and targeted therapy.
Immunotherapy.

Leading key specialties

Lymphoma & Myeloma Center

Department Overview

The Lymphoma and Myeloma Center is a key specialized diagnosis and treatment center of Lu Daopei Medical Group, featuring precise diagnosis, difficult and relapsed disease treatment, and CAR-T therapy, providing high-quality, personalized medical services for patients. The center has a special consultant from Peking Union Medical College Hospital, Professor Zhou Daobin (Chief Physician, Doctoral Supervisor).

Core Technologies

Precise Lymphoma Diagnosis – MICM classification
Individualized Myeloma Treatment – New drug combinations
CAR-T Cell Therapy – Relapsed/refractory lymphoma/myeloma
Hematopoietic Stem Cell Transplantation – Consolidation therapy
Pathology Consultation – Lymphoma pathological diagnosis

Areas of expertise:

Lymphoplasmacytic diseases.
Leukemia.
Hematopoietic stem cell transplantation.

Leading key specialties

Pathology & Laboratory Medicine

Department Overview

The Pathology and Laboratory Medicine Department is an important supporting department of the hospital, with 9 specialized laboratories including Cell Morphology, Molecular Medicine, Flow Cytometry, Cytogenetics and Molecular Cytogenetics, Clinical Pharmacology, Pathology, and Pathogenic Microbiology. The accuracy and readability of test reports are widely recognized in the industry.

Core Technologies

MICM Diagnostic System – Morphology, Immunology, Cytogenetics, Molecular biology
Minimal Residual Disease Monitoring
Cell Morphology Diagnosis – Bone marrow cell morphology analysis
Flow Cytometry – Immunophenotyping
Molecular Gene Testing – Hematological disease gene mutations

Areas of expertise:

Cell morphology diagnosis of leukemia.
Lymphoma diagnosis.
Morphological diagnosis of anemia and other hematological diseases.

Advantages of Cutting-Edge Diagnostic and Treatment Technologies

Multiple transplantation approaches are available, including haploidentical, unrelated donor, sibling-matched, and cord blood hematopoietic stem cell transplantation.

CAR-T cell immunotherapy is used in the treatment of selected relapsed and refractory hematological malignancies, including leukemia, lymphoma, and multiple myeloma.

Integrated morphology, immunology, cytogenetics, and molecular biology support precise classification and diagnosis of hematological diseases.

MRD monitoring supports treatment response assessment and disease management for patients with leukemia, lymphoma, and other hematological malignancies.

MDT (Multidisciplinary Team) Consultation System

Multidisciplinary Care for Complex Hematological Diseases

The hospital integrates expertise in hematopoietic stem cell transplantation, general hematology, lymphoma and myeloma treatment, pathology, laboratory medicine, immunotherapy, and imaging to support the diagnosis and treatment of complex hematological diseases.

Multidisciplinary collaboration supports individualized treatment planning for patients with refractory and relapsed leukemia, lymphoma, multiple myeloma, transplantation complications, and other complex hematological conditions.

Modern Medical Facilities and Patient-Centered Care

Specialized hematology facilities, Class 100 laminar flow rooms, advanced laboratory equipment, and dedicated inpatient environments support comprehensive hematological care.

Hospital Environment

Hospital Exterior

Outpatient Area

Nursing Station

Public Space

Hematology Ward

High-end medical equipment

Flow Cytometer

Advanced flow cytometry supports immunophenotyping, hematological disease diagnosis, and minimal residual disease monitoring.

PCR Amplifier

PCR amplification equipment supports molecular diagnostics and genetic testing for hematological diseases.

Blood Cell Separator

Blood cell separation equipment supports specialized hematological treatment and clinical procedures.

Specialized Hematology Environment

Specialized facilities for hematological disease treatment.
Dedicated transplantation and hematology wards.
36 Class 100 laminar flow sterile rooms.
ICU facilities for patients requiring intensive monitoring.

High-End Ward Amenities

Class 100 sterile environment for transplantation patients.
Independent ventilation system.
VIP suites, single, double, and triple rooms available.
Transplant laminar flow room reference: approximately ¥1,500–3,000/night.

Patient Accommodation Options

Hyatt Regency Beijing Wangjing — 15-min drive, ¥1,200–2,500/night.
Holiday Inn Express Beijing Wangjing — 10-min drive, ¥400–700/night.
Home Inn Beijing Yizhuang — 8-min drive, ¥250–450/night.

Location and Transportation